Wednesday, September 23, 2026

LeMaitre Vascular, Inc. And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

January 1, 2021

LeMaitre Vascular, Inc. And 3 Other Stocks Have Very High Payout Ratio
We have gathered information in relation to stocks with the highest payout ratio at the moment. The payout ratio in itself isn't a assurance of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them. When investigating a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.

1. LSI Industries Inc.

76.92% Payout Ratio

LSI Industries Inc. provides corporate visual image solutions in the United States, Canada, Mexico, Australia, and Latin America. As maintained by Morningstar, Inc., the next dividend payment is on Nov 5, 2020, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 2.41%. LSI Industries Inc.'s sales growth this year is expected to be negative 4.4% and 23.7% for next year. Year-on-year quarterly revenue growth declined by 21.1%, now sitting on 286.86M for the twelve trailing months. The company's growth estimates for the next quarter is 250%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.67%.

Volatility

LSI Industries Inc.'s last day, last week, and last month's average volatility was 0.12%, 0.28%, and 0.28%, respectively. LSI Industries Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.06%, 4.96%, and 4.25%, respectively.

LSI Industries Inc.'s Stock Yearly Top and Bottom Value

LSI Industries Inc.'s stock is valued at $8.35 at 22:23 EST, under its 52-week high of $9.01 and way higher than its 52-week low of $2.50.

LSI Industries Inc.'s Moving Average

LSI Industries Inc.'s worth is above its 50-day moving average of $7.87 and way above its 200-day moving average of $6.94.

2. LeMaitre Vascular, Inc.

40.66% Payout Ratio

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. According to Morningstar, Inc., the next dividend payment is on Nov 17, 2020, the estimated forward annual dividend rate is 0.38 and the estimated forward annual dividend yield is 1%. LeMaitre Vascular, Inc.'s sales growth this year is expected to be 8.7% and 14.6% for next year. Year-on-year quarterly revenue growth grew by 25.1%, now sitting on 121.99M for the twelve trailing months. LeMaitre Vascular, Inc.'s sales growth for the current quarter is 15.9%. The company's growth estimates for the current quarter and the next is 30.4% and 43.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.4%.

Volatility

LeMaitre Vascular, Inc.'s last day, last week, and last month's average volatility was a negative 2.09%, a positive 0.74%, and a negative 0.05%, respectively. LeMaitre Vascular, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 3.89%, 3.33%, and 4.16%, respectively.

LeMaitre Vascular, Inc.'s Stock Yearly Top and Bottom Value

LeMaitre Vascular, Inc.'s stock is valued at $38.10 at 22:23 EST, below its 52-week high of $41.86 and way above its 52-week low of $18.76.

LeMaitre Vascular, Inc.'s Moving Average

LeMaitre Vascular, Inc.'s value is higher than its 50-day moving average of $37.20 and way above its 200-day moving average of $31.70.

3. BOK Financial Corporation

36.76% Payout Ratio

BOK Financial Corporation operates as the financial holding company for BOKF, NA that provides various financial products and services in Oklahoma, Texas, New Mexico, Northwest Arkansas, Colorado, Arizona, and Kansas/Missouri. As stated by Morningstar, Inc., the next dividend payment is on Nov 12, 2020, the estimated forward annual dividend rate is 2.08 and the estimated forward annual dividend yield is 3.06%. BOK Financial Corporation's sales growth this year is anticipated to be 10% and a negative 3.4% for next year. Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 1.66B for the twelve trailing months. BOK Financial Corporation's sales growth is 12.3% for the current current quarter and 6.8% for the next. The company's growth estimates for the ongoing quarter and the next is 21.8% and 102.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.77%.

Volatility

BOK Financial Corporation's last day, last week, and last month's average volatility was a positive 0.12%, a negative 0.57%, and a negative 0.12%, respectively. BOK Financial Corporation's last day, last week, and last month's high and low average amplitude percentage was 4.42%, 2.78%, and 2.55%, respectively.

BOK Financial Corporation's Stock Yearly Top and Bottom Value

BOK Financial Corporation's stock is valued at $68.00 at 22:23 EST, way under its 52-week high of $87.97 and way above its 52-week low of $34.57.

BOK Financial Corporation's Moving Average

BOK Financial Corporation's value is under its 50-day moving average of $68.19 and way higher than its 200-day moving average of $59.19.

4. Aberdeen Japan Equity Fund, Inc.

53.99% Payout Ratio

Aberdeen Japan Equity Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. As claimed by Morningstar, Inc., the next dividend payment is on Dec 29, 2020, the estimated forward annual dividend rate is 0.43 and the estimated forward annual dividend yield is 4.5%. Aberdeen Japan Equity Fund, Inc. 's sales growth this year is anticipated to be negative 0% and a negative 0% for next year. Year-on-year quarterly revenue growth declined by 0.8%, now sitting on 1.81M for the twelve trailing months. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.63%.

Volatility

Aberdeen Japan Equity Fund, Inc. 's last day, last week, and last month's average volatility was 3.01%, 0.96%, and 0.24%, respectively. Aberdeen Japan Equity Fund, Inc. 's last day, last week, and last month's high and low average amplitude percentage was 2.79%, 1.82%, and 1.82%, respectively.

Aberdeen Japan Equity Fund, Inc. 's Stock Yearly Top and Bottom Value

Aberdeen Japan Equity Fund, Inc. 's stock is valued at $9.94 at 22:23 EST, way under its 52-week low of $5.00.

Aberdeen Japan Equity Fund, Inc. 's Moving Average

Aberdeen Japan Equity Fund, Inc. 's value is higher than its 50-day moving average of $9.29 and way higher than its 200-day moving average of $8.27.
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com